COVID-19 and Biotech

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/20/2021 Sinovac vaccine 80% effective against COVID-19-related death ‚Äì Chilean gov‚Äôt study Telegram Sinovac vaccine 80% effective against COVID-19-related death ‚Ai Chilean gov‚Aot studyTHE Coronavirus (COVID-19) vaccine developed by China‚Aos Sinovac Biotech Ltd is 80 percent effective against death from the disease, a recent real-world study in Chile has shown.The Sinovac vaccine is also 67 percent effective in preventing symptomatic infection, 85 percent effective in preventing hospitalizations, and 89 percent effective in preventing patients ...
4/20/2021 Sinovac vaccine 80 pct effective against COVID-19-related death: Chilean gov‚Äôt study Sinovac vaccine 80 pct effective against COVID-19-related death: Chilean gov‚Aot studyThe COVID-19 vaccine developed by China‚Aos Sinovac Biotech Ltd is 80 percent effective against death from the disease, showed a recent real-world study in Chile.The Sinovac vaccine is also 67 percent effective in preventing symptomatic infection, 85 percent effective in preventing hospitalizations and 89 percent in preventing patients from entering intensive care ...
4/20/2021 Bharat Biotech, government cash and partners in hand, aims for 700M COVID-19 shots per year FiercePharma With COVID-19 cases mounting, India has equipped local drugmaker Bharat Biotech with government cash to rapidly scale up its vaccine output this year.Bharat plans to upgrade at two plants to boost production of its COVID-19 vaccine Covaxin to nearly 700 million doses a year, Mint reports. The lift comes after the Indian government awarded the drugmaker nearly $200 million to upgrade capacity amid a sharp rise in ...
4/20/2021 Federal Budget Recognizes Strategic Importance of Canada's Biotech Sector | Business Wire Business Wire Federal Budget Recognizes Strategic Importance of Canada‚Aos Biotech Sector April 19, 2021 06:49OTTAWA, Ontario- The federal budget highlighted the vital role biotechnology innovation is playing in addressing the COVID-19 pandemic while aiming to prepare for future pandemic needs and serves as one of the identified key sectors set to drive the economic recovery for Canada. Biotechnology featured as a priority area for the government across many program ...
4/19/2021 India to fund capacity boost at Serum Institute as vaccines run short - source Yahoo News By Aftab AhmedNEW DELHI (Reuters) -India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech to boost production capacity as infections spread at record speed, its finance minister said.Of the total, SII, the world's biggest maker of vaccines including the AstraZeneca shot, will get 30 billion rupees ($400 million), Nirmala Sitharaman told news channel ...
4/19/2021 Global Vaccine Contract Manufacturing Market Outlook and Forecast 2021-2026: Vaccination Programs For COVID-19 - Vaccine Pipeline Boosting Demand - ResearchAndMarkets.com Yahoo News ... 13% during the period 2020-2026.The global vaccine contract manufacturing market has experienced radical transformations after the outbreak of the COVID-19 pandemic, which has been a massive health catastrophe.Vaccine CMOs have gained significant ... dramatically over few decades. Almost three-fourths of pharma and biotech companies have entered into mergers and agreements with contract manufacturers to develop COVID-19 vaccines. Outsourcing has gained high significance as it offers significant ...
4/19/2021 Antibody Startup Adagio Raises $336 Million To Develop A Variant-Proof Treatment For Covid-19 Forbes T illman Gerngross has a simple goal: he wants to find one antibody that can both treat and prevent Covid-19, no matter how much the virus mutates. While many biotech companies are obsessed with making a vaccine, Gerngross‚Ao company Adagio is going all-in on the promise of monoclonal antibodies, engineered human antibodies that can bind with and neutralize the SARS-CoV-2 virus. It already has a ...
4/19/2021 4 Business Opportunities in Singapore for 2021 PRSync ... COVID-19 and the new economic strife, more employees are turning to work from home. While the pandemic is driving people away from traditional brick and mortar businesses, it has also brought about unexpected changes and new business opportunities.One hot business idea in Singapore today is biotechnology. ‚Au Biotechnology is a rapidly changing, future-proof industry that will help to prevent the next pandemic. Many nations across the globe ...
4/18/2021 First Dose of Chinese Covid-19 Vaccine Offers Little Protection, Chile Learns - WSJ The Wall Street Journal ... Covid-19. The 61-year-old was hospitalized near his home in the Chilean capital, Santiago, for nine days and needed supplemental oxygen to pull through.Across Chile‚Aiwhich has mounted one of the world‚Aos most rapid vaccination campaigns using the vaccine made by Chinese drugmaker Sinovac Biotech Ltd.‚Aihealth authorities are scrambling to deal with a surge in new infections and deaths.More than 7.6 million people, half ...
4/18/2021 India is dealing with a vaccine shortage during a new wave of Covid-19 Vox India is the second most populous nation and the largest producer of Covid-19 vaccines worldwide, thanks to being home to the Serum Institute of India (SII) ‚Ai a biotech and pharmaceuticals company responsible for 60 percent of the globe‚Aos entire vaccine supply, according to a CNN report .But recent US and European limits on the exportation of critical Covid-19 vaccine production materials have resulted in a severe ...
4/16/2021 South Korea consortium to produce Russia's Sputnik V Covid vaccine CNBC File labelled "Sputnik V coronavirus disease (COVID-19) vaccine", March 24, 2021. Dado Ruvic Reuters South Korea's Huons Global said on Friday it will lead a consortium to produce 100 million doses of Russia's Sputnik V Covid-19 vaccine per month as Moscow ramps up production for supplies abroad.The announcement comes after South Korean biotech firm GL Rapha signed a deal with Russia's sovereign wealth fund late last year ...
4/16/2021 Regeneron antibodies cocktail could be a boon for unvaccinated workers Crain's New York Business Reprints PrintA drug under federal review could speed up the city's return to normalcy by helping to prevent unvaccinated people exposed to Covid-19 from getting sick.Regeneron, a biotech company based in Tarrytown, announced Monday that its drug REGEN-COV reduced the risk of developing symptomatic Covid-19 by 81% in individuals exposed to the virus. The company is now asking the U.S. Food and Drug Administration for ...
4/15/2021 Journalists reporting from adverse situations should be allowed Covid vaccination on priority: Kejriwal ... Covid-19 pandemic with the number of new cases increasing each day. The country reported 1,84,372 new Covid-19 cases and 1,027 related deaths on Tuesday.India had started the Covid-19 vaccination drive on January 16 with two vaccines - Covishield ( Oxford-AstraZeneca 's vaccine manufactured by Serum Institute of India ) and Covaxin (manufactured by Bharat Biotech Limited).India commenced its second phase of the Covid-19 vaccination drive to ...
4/15/2021 India logs over 2 lakh COVID-19 cases for first time ever; Centre plans Oxygen review ... informed that the number of samples tested on April 14 is 13,84,549. Meanwhile, the Health Department, the cumulative number of COVID-19 vaccine doses administered in the country so far stands at 11,44,3,238 . READ France ... in addition to Covishielf and Covaxin.CovaxinManufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology, it uses an inactivated virus. It is developed by ...
4/15/2021 GeNeuro's experimental multiple sclerosis drug shows hints it may help treat COVID-19 | FierceBiotech FierceBiotech The clinical manifestations of COVID-19 are believed to be caused by an abnormal immune response to the novel coronavirus, SARS-CoV-2. Targeting that rogue immune response is one of the approaches under investigation ... by drugs designed to treat the disease.Scientists from Swiss biotech GeNeuro also participated in the study. The company is developing an anti-HERV-W antibody, temelimab, to treat multiple sclerosis. It's in phase 2 ...
4/15/2021 CureVac says it is on track with COVID-19 vaccine as it posts earnings update - MarketWatch MarketWatch ... biotech posted an annual operating loss of ‚C¨109.8 million ($130.41 million) for the 12 months ending December 2020, an increase of 10.4% from the year before. Annual revenue was ‚C¨48.9 million.The company, which went public last August, struck an agreement with the U.K. last month to produce 50 million doses of a COVID-19 vaccine aimed at targeting different variants of coronavirus.It said on Thursday its ...
4/15/2021 Why India Needs To Locally Develop Critical Raw Materials For Vaccine Production Why India Needs To Locally Develop Critical Raw Materials For Vaccine Production by Swarajya Staff - Apr 15, 2021 11:55 AM Covid-19 vaccine - representative image (Twitter) SnapshotShortage of crucial production inputs, including single-use bioreactor bags, beta propiolactone and thimerosal are threatening to scale down ambitious production targets of Indian Vaccine ManufacturersIn the wake of a shortage of raw materials to produce Covid-19 vaccines, Bharat Biotech International ...
4/14/2021 Novavax CFO to step down, biotech company says - MarketWatch MarketWatch ... biotech also said it promoted Gale E. Smith to chief scientist and Troy Morgan as chief compliance officer. Executive Vice President John J. Trizzino will assume the role of CFO while the company searches for a permanent replacement. Novavax said last week it will expand clinical trials of its COVID-19 vaccine candidate to include children and teens. Earlier this year, the company said it hoped to get an emergency ...
4/14/2021 JNJ Vaccine Pause Gives Stay-at-Home ETFs a Shot in the Arm - April 14, 2021 - Zacks.com Zacks ... COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus ).The studies have shown that the Johnson & Johnson vaccine is 66% effective in preventing cases of moderate-to-severe illness and 85% effective against severe cases of COVID-19. It completely prevented hospitalizations and death four weeks after inoculation, according to studies. The company was on course to provide 100 million doses by the end of May.The pause ...
4/14/2021 Janssen COVID-19 Vaccine Frequently Asked Questions (Updated April 14, 2021) Janssen COVID-19 Vaccine Frequently Asked Questions (Updated April 14, 2021) Audience: Consumer, Patient, Health Professional, Pharmacy On February 27, 2021, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the ... 40,000 thousand study participants and manufacturing information submitted by Janssen Biotech, Inc. The FDA has determined that the totality of the available data provides clear evidence that Janssen COVID-19 Vaccine may be effective in ...
4/13/2021 India deals mean Russia's Sputnik V vaccine finally has manufacturing muscle | Fortune Fortune On Monday, Indian regulators approved Russia‚Aos Sputnik V COVID-19 vaccine. Now, the state-backed Russian Direct Investment Fund (RDIF), which is marketing the Sputnik V vaccine, has plans to make the world‚Aos ... Institute of India and the other from Indian firm Bharat Biotech.But the Sputnik V vaccine provides India with potentially its most potent weapon in the country‚Aos battle to contain COVID-19.Sputnik V ...
4/13/2021 Novavax CFO to step down, biotech company says - MarketWatch MarketWatch ... biotech also said it promoted Gale E. Smith to chief scientist and Troy Morgan as chief compliance officer. Executive Vice President John J. Trizzino will assume the role of CFO while the company searches for a permanent replacement. Novavax said last week it will expand clinical trials of its COVID-19 vaccine candidate to include children and teens. Earlier this year, the company said it hoped to get an emergency ...
4/13/2021 Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public ... Biotech Corp . announced today that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody test to the public via physician screening. GenScript's cPass‚N¢ SARS-CoV-2 Neutralization Antibody Detection Kit is the first test authorized by the U.S. Food and Drug Administration to detect neutralizing antibodies (NAbs), the specific antibodies present in the serum of COVID-19 patients that are responsible for blocking the viral infection and ...
4/12/2021 Korea's Outstanding SMEs as Frontline Fighters against COVID-19 Yahoo News ... of prophylaxis industry to enter the global procurement-as-a-service market, as the government-entrusted organizing agency of the COVID-19 quarantine project, Marketing Support for Companies Specialized in Bio-functional Material in Global ... SD Foods, En-O-En, BioAlpha Cosmos, Ercohs, and Eugene Biotech.BSR Korea, the agency specialized in the public sector, has extensive experience in preparing short- and medium-term frameworks, such as planning for emergency ...
4/12/2021 Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO | FierceBiotech FierceBiotech Apr 12, 2021 8:10am Bill Enright, Vaccitech CEO (Vaccitech) U.K. vaccine and cancer biotech Vaccitech, now famous (and perhaps in some quarters, infamous) for its tech that delivered the AstraZeneca-University of Oxford COVID-19 vaccine, is gunning for an IPO. The biotech, a spinout company from Oxford's Jenner Institute, one of the oldest and most renowned vaccine research centers in the world, wants a $100 million IPO as it ...